KMC Speciality Hospitals Intrinsic Value
KMC Speciality Hospitals (KMCSHIL) median intrinsic value is ₹102.50 from 9 valuation models (range ₹29–₹242), vs current price ₹96.77 — +5.9% upside (Trading Near Calculated Value), margin of safety 5.6%. Also explore KMC Speciality Hospitals stock price data download to track price trends across different timeframes.
KMCSHIL Valuation Methods Summary — DCF, Graham Number & P/E
KMC Speciality Hospitals intrinsic value across 9 models vs current price ₹96.77 — upside/downside and value range per method. For current market price and key ratios, visit KMCSHIL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹29.03 | ₹23.22 - ₹34.84 | -70.0% | EPS: ₹2.20, Sector P/E: 12x |
| Book Value Method | asset | ₹102.50 | ₹92.25 - ₹112.75 | +5.9% | Book Value/Share: ₹102.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹144.00 | ₹129.60 - ₹158.40 | +48.8% | Revenue/Share: ₹180.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹193.54 | ₹174.19 - ₹212.89 | +100.0% | EBITDA: ₹82.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹241.92 | ₹193.54 - ₹290.30 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹29.03 | ₹26.13 - ₹31.93 | -70.0% | EPS Growth: 11.0%, Fair P/E: 8.8x |
| Growth Adjusted P/E | growth | ₹29.03 | ₹26.13 - ₹31.93 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹193.54 | ₹174.19 - ₹212.89 | +100.0% | ROE: 22.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹71.23 | ₹64.11 - ₹78.35 | -26.4% | EPS: ₹2.20, BVPS: ₹102.50 |
KMCSHIL Intrinsic Value vs Market Price — All Valuation Models
KMC Speciality Hospitals fair value range ₹29–₹242 vs current market price ₹96.77 across 9 valuation models. Browse KMC Speciality Hospitals annual reports for revenue, profit, balance sheet and cash flow data.
KMCSHIL Intrinsic Value Analysis — Undervalued or Overvalued?
KMC Speciality Hospitals median intrinsic value ₹102.50, current price ₹96.77 — Trading Near Calculated Value by 5.9%, margin of safety 5.6%.
What is the intrinsic value of KMCSHIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of KMC Speciality Hospitals (KMCSHIL) is ₹102.50 (median value). With the current market price of ₹96.77, this represents a +5.9% variance from our estimated fair value.
The valuation range spans from ₹29.03 to ₹241.92, indicating ₹29.03 - ₹241.92.
Is KMCSHIL undervalued or overvalued?
Based on our multi-method analysis, KMC Speciality Hospitals (KMCSHIL) appears to be trading near calculated value by approximately 5.9%.
KMCSHIL Financial Health — Key Ratios vs Industry Benchmarks
KMC Speciality Hospitals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.39 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 22.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.01x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KMCSHIL Cash Flow Quality — Operating & Free Cash Flow
KMC Speciality Hospitals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹58 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹38 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹32 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹29 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹26 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |